Glandular fever symptoms usually start slowly: deep fatigue, fever, a sore throat that gets worse over several days, swollen tonsils with a whitish-yellow coating, and swollen, tender lymph nodes in the neck. Glandular fever (infectious mononucleosis, or "mono") is most often caused by the Epstein-Barr virus (EBV), and the CDC says symptoms usually appear 4 to 6 weeks after infection.
Most people feel better in 2 to 4 weeks, but tiredness can last for weeks and, occasionally, for 6 months or longer. There is no cure, so treatment means rest, fluids and pain relief. The two practical points that matter most are avoiding contact sport while the spleen may be enlarged, and not taking amoxicillin or ampicillin, which can trigger a rash. A blood count and a mono test confirm most cases.
Key takeaways
- Mono causes fever, sore throat and swollen lymph nodes, plus marked fatigue, mostly between ages 15 and 24.
- The rapid monospot test is often falsely negative in children under 5 and in the first week of illness. EBV antibodies (VCA IgM, VCA IgG, EBNA) then date the infection.
- A complete blood count with more than 50% lymphocytes and more than 10% atypical lymphocytes strongly points to mono. Liver enzymes are raised in about 6 in 10 people.
- The spleen is enlarged in about half of cases. Rupture is rare (0.1 to 0.5%), but 1 in 4 happens after day 21: no contact sport for at least 3 to 4 weeks.
- EBV is strongly linked to multiple sclerosis, and several EBV vaccines are in trials; none is approved yet.
What is infectious mononucleosis?
Infectious mononucleosis is a viral illness defined by fever, sore throat and swollen lymph glands. MedlinePlus calls it "the kissing disease"; in the UK it is usually called glandular fever.
EBV, also called human herpesvirus 4, causes most cases. Other germs can cause a similar "mono-like" illness, including cytomegalovirus (CMV), toxoplasmosis, HIV, rubella, hepatitis viruses and adenovirus, according to MedlinePlus. Our guide to CMV blood tests and IgG and IgM results explains one of the most common look-alikes.
EBV is extremely common: more than 90% of adults have been infected, according to the CDC. Children often catch it without symptoms, and the CDC estimates that at least 1 in 4 teens and young adults infected with EBV will develop mono. The virus then stays in the body for life. Our article on EBV reactivation and what blood tests show covers what happens when the virus becomes active again.
How glandular fever spreads and who gets it
EBV spreads mainly through saliva: kissing, but also sharing a fork, spoon, glass, straw, food, toothbrush or lip balm. The virus can also spread through blood and semen during sexual contact, blood transfusions and organ transplants, MedlinePlus explains.
People with mono may be contagious while they have symptoms and for up to a few months afterwards. The CDC advises not kissing people who have mono and not sharing drinks, food or personal items with them.
A 2023 review in American Family Physician (AFP) notes that mono most often affects people aged 15 to 24, and that people with weakened immune systems are at higher risk of severe disease. The CDC adds that university students are especially affected.
Glandular fever symptoms
Symptoms may develop slowly and may not all occur at the same time, the CDC notes. MedlinePlus describes a typical course: it starts with fatigue, a general ill feeling, headache and sore throat; the throat slowly gets worse; the tonsils swell and develop a whitish-yellow covering; and the lymph nodes in the neck become swollen and painful.
Common symptoms
- extreme fatigue and drowsiness;
- fever;
- sore throat and swollen tonsils;
- swollen lymph nodes, mainly in the neck and armpits;
- headache, muscle aches and loss of appetite;
- a rash;
- a swollen spleen or liver, less often.
A 2024 review in Current Pediatric Reviews adds that puffy eyelids (periorbital oedema) occur in about one third of patients, the spleen is enlarged in about 50% and the liver in about 10%. MedlinePlus adds less common signs such as cough, hives, nosebleeds and jaundice.
Glandular fever or strep throat?
Both cause fever and a painful throat with white patches. A 2021 meta-analysis of 17 studies found that swollen nodes at the back of the neck, in the armpits or groin, tiny red spots on the palate and an enlarged spleen make mono more likely, but no symptom can rule it out. If only one tonsil is swollen, read our guide to unilateral tonsillitis and its red flags.
Glandular fever in young children and in adults
Young children often have no symptoms, or a mild illness that looks like a cold or the flu. Adults over 35 are more likely to develop hepatitis with jaundice, according to MedlinePlus. Mono is rare in older adults, so it can be missed.
How long does glandular fever last?
Here is the usual timeline, combining CDC, MedlinePlus and a 2022 systematic review of liver tests:
- Incubation: 4 to 6 weeks between infection and the first symptoms.
- Fever: usually drops within about 10 days; most people feel better in 2 to 4 weeks.
- Swollen lymph glands and spleen: usually heal in about 4 weeks, although the CDC notes the liver or spleen can stay enlarged after fatigue ends.
- Liver tests: return to normal after a median of 8 weeks (range up to more than 6 months).
- Fatigue: usually goes away within a few weeks but may linger for 2 to 3 months, and occasionally for 6 months or longer.
Some people develop long-lasting exhaustion. In a prospective study of 301 adolescents published in Pediatrics, 13% met the criteria for chronic fatigue syndrome (ME/CFS) 6 months after mono, 7% at 12 months and 4% at 24 months; most recovered with time. In adults, a 2025 review reports 11% at 6 months and 9% at 1 year. The CDC advises looking for other causes when someone is ill for more than 6 months without a lab-confirmed EBV diagnosis. Our article on blood tests for fatigue explains which tests help.
The glandular fever test and other blood tests
A doctor can often recognise typical mono from the symptoms and the exam. The CDC says lab tests are usually not needed for a typical case but help in atypical or severe ones. In practice, AFP recommends two quick first tests: a complete blood count with a differential and a rapid heterophile antibody test.
Monospot (heterophile antibody) test
The monospot detects heterophile antibodies, which the immune system makes during mono. Results are usually ready within an hour, from a finger-prick or a blood draw. According to AFP, the test has a sensitivity of 87% and a specificity of 91%. Its weak points are well known:
- False negatives in children younger than 5 years, who often do not make heterophile antibodies.
- False negatives in adults during the first week of illness, before the antibodies appear.
- False positives in some other conditions. For this reason, the CDC says a positive result suggests typical mono but does not prove EBV infection.
EBV antibody panel: VCA IgM, VCA IgG and EBNA
When the monospot is negative but symptoms persist, or the case is unusual, doctors order EBV-specific antibodies. The CDC laboratory page describes how each one behaves:
- VCA IgM (antibody to the viral capsid antigen, IgM class) appears early and usually disappears within 4 to 6 weeks. Our page on the IgM blood test explains this "early" antibody class.
- VCA IgG appears in the acute phase, peaks 2 to 4 weeks after onset and then stays for life.
- EA (early antigen) IgG appears in the acute phase and usually becomes undetectable after 3 to 6 months, but about 20% of healthy people keep it for years.
- EBNA (Epstein-Barr nuclear antigen) antibody is absent in the acute phase, appears 2 to 4 months after the start of symptoms and persists for life.
Complete blood count and atypical lymphocytes
A complete blood count is very informative in mono. The white blood cell count is often high, and lymphocytes make up at least 50% of white cells. Atypical lymphocytes, larger and different-looking cells seen on the blood smear, make up more than 10%. In the 2021 meta-analysis, the combination of lymphocytes above 50% and atypical lymphocytes above 10% had a positive likelihood ratio of 50, which makes mono very likely. The CDC adds that neutrophils or platelets may be low. Our guide to high lymphocytes and next steps lists the other causes of a raised lymphocyte count.
Liver enzymes (ALT, AST)
EBV commonly causes a mild hepatitis. In a 2022 systematic review of 32 studies, abnormal results were found for ALT in 62% of patients, AST in 57%, alkaline phosphatase in 65%, GGT in 41% and bilirubin in 16%. No patient developed liver failure, and the authors conclude that repeated liver tests and abdominal ultrasound are not routinely needed in people with a normal immune system. AFP adds that raised liver enzymes make mono more likely when the monospot is negative.
Glandular fever test results: reference table
This table summarises typical findings in acute EBV mono. Your lab's own reference ranges may differ slightly; percentages are the same in SI and US units.
| Test | Typical result in acute glandular fever (SI unit / US unit) | What it means |
|---|---|---|
| Lymphocytes | More than 40 to 50% of white cells; more than 4 × 10⁹/L (4,000 cells/µL) | Helps rule in mono (2021 meta-analysis) |
| Atypical lymphocytes | More than 10% (of white cells or lymphocytes) | With lymphocytes above 50%, strongly suggests mono |
| Platelets, neutrophils | Sometimes below the lab's lower limit | Usually temporary (CDC) |
| ALT, AST (U/L in both systems) | Above the upper limit in about 6 in 10 patients | Mild EBV hepatitis; normal again after a median of 8 weeks |
| Monospot (heterophile) | Positive | Supports mono; a negative result does not exclude it early on or in children under 5 |
| VCA IgM positive, EBNA negative | Antibody pattern | New (primary) EBV infection |
| VCA IgG and EBNA positive | Antibody pattern | Past infection, months to years ago |
| No VCA antibodies | Antibody pattern | Never infected (susceptible): look for another cause |
How to read your results
A positive monospot with typical symptoms and a lymphocyte-rich blood count usually settles the question. If the monospot is negative, look at the EBV panel: VCA IgM without EBNA means a recent infection, and the CDC adds that a high VCA IgG without EBNA after at least 4 weeks of illness also strongly suggests it. High VCA IgG alone does not mean a recent infection. If both VCA and EBNA are positive, your current illness is probably due to something else, such as CMV, strep or toxoplasmosis; our page on lymphocyte normal ranges helps you place your count in context.
Complications of glandular fever
Most people recover without problems. The complications below are uncommon, but knowing the warning signs is what keeps mono safe.
Enlarged spleen and splenic rupture
EBV mono always involves the spleen, the 2023 review notes. Spontaneous rupture occurs in 0.1 to 0.5% of patients. A 2023 systematic review in Swiss Medical Weekly gathered 186 cases of splenic rupture: only 9.1% followed an injury, about 80% happened within three weeks of the first symptoms, and 4.8% were fatal. Sharp, sudden, severe belly pain, especially on the upper left side, is an emergency. Surgeons now try to save the spleen whenever possible.
Airway obstruction
Very large tonsils and swollen throat tissue can narrow the airway. A 2026 meta-analysis in Frontiers in Pediatrics found that clinically significant upper airway obstruction was the most consistently documented life-threatening ear, nose and throat complication, affecting about 21% of children hospitalised for mono (low-certainty evidence, two cohorts). The CDC also lists peritonsillar abscess, sinusitis and infected lymph nodes. Trouble swallowing or breathing needs emergency care.
The mono rash and amoxicillin
A widely scattered, red, flat-to-raised rash affects 10 to 45% of people with mono, the 2024 review reports. It is more likely if you receive ampicillin or amoxicillin for a presumed throat infection. A 2025 meta-analysis in the European Journal of Clinical Microbiology and Infectious Diseases (15 studies, 3,153 patients) found a rash in 43% after an aminopenicillin, 15% after other antibiotics and 14% without antibiotics, with an odds ratio of 5.4. In recent studies (2012 to 2024), the figure after aminopenicillins fell to 18%, much lower than the 84% of the 1960s and 1970s: the authors conclude the risk is much lower than doctors believe. Our article on rash from amoxicillin versus a true allergy explains how doctors tell the two apart.
Other complications
MedlinePlus lists haemolytic anaemia (red cells destroyed early), hepatitis with jaundice, swollen testicles and rare nervous system problems such as Guillain-Barré syndrome, meningitis, seizures and Bell palsy. In people with a severely weakened immune system, EBV can cause serious disease.
Glandular fever treatment and home care
There is no specific cure. The goal is to relieve symptoms while the immune system clears the acute infection:
- rest as much as you need, and drink plenty of fluids;
- gargle with warm salt water or suck on lozenges for the sore throat;
- take paracetamol or ibuprofen for pain and fever, following the label; never give aspirin to children under 16 because of the risk of Reye's syndrome;
- do not take penicillin antibiotics such as ampicillin or amoxicillin unless a test shows a bacterial infection that needs them.
Steroids and antivirals
AFP states that routine use of antivirals and corticosteroids is not recommended. A Cochrane review of steroids (7 trials, 362 participants) found no benefit in 8 of 10 measures of recovery, with only a short-lived improvement in sore throat. MedlinePlus notes that prednisone may be given when symptoms are severe. A Cochrane review of antivirals (acyclovir, valacyclovir and valomaciclovir; 7 trials, 333 participants) found very low-quality evidence: viral shedding fell only while the drug was taken, and the benefit on recovery was uncertain. Valacyclovir (an oral prodrug of acyclovir, ChEMBL) is therefore not standard care.
Return to sport after glandular fever
This is where advice matters most for teens and athletes. Guidance is based on rupture case reports, not trials, so recommendations vary:
- AFP (2023): no athletic activity for 3 weeks from the start of symptoms, then a shared decision with your doctor on the timing of return.
- A study of 42 US military health system cases (Sports Health, 2019): the average time to splenic injury was 15.4 days, but only 73.8% happened within 21 days and 90.5% within 31 days, so the authors suggest restricting activity for 31 days.
- The 2024 Current Pediatric Reviews article: avoid contact sport and strenuous exercise for 8 weeks or while the spleen is still enlarged.
A 2014 sports medicine review warns that the physical exam is unreliable for spleen size and ultrasound has limits, so the decision is individual. A sensible plan is light walking once the fever is gone, no contact or collision sport and no heavy lifting for at least 3 to 4 weeks, then a gradual return once your doctor is satisfied that the spleen is no longer enlarged and you have the energy.
Recovery, fatigue and mood
Fatigue is often the last symptom to leave. Return to school or work gradually and plan rest breaks. The 2014 sports medicine review found that exercise does not appear to put young athletes at risk of chronic fatigue, so a slow, symptom-guided increase in activity is reasonable once the spleen is safe.
Mono can also affect mood. A Danish nationwide study of 1.4 million people (Brain, Behavior, and Immunity, 2021) found that hospital-diagnosed mono in childhood or adolescence was linked to a 40% higher risk of later depression. Talk to your doctor if low mood, anxiety or sleep problems last beyond the acute illness.
Prevention
There is no vaccine for mono yet, the CDC notes. While someone is ill, avoid kissing them and do not share drinks, cutlery, toothbrushes or lip balm. Wash hands and clean shared items.
When to see a doctor
See a GP if symptoms last more than 10 days, or if you develop belly pain, a persistent high fever above 38.6°C, a severe headache, a very sore throat or very swollen tonsils, weakness in the arms or legs, or yellow skin or eyes, as MedlinePlus advises.
Call 999 or go to A&E for:
- sudden, sharp, severe pain in the abdomen, especially on the upper left side, or fainting: possible spleen rupture;
- trouble breathing or swallowing, drooling or noisy breathing;
- a stiff neck, confusion, seizures or severe weakness.
Latest scientific advances in mononucleosis
Mono, EBV and multiple sclerosis: stronger evidence
A landmark 2022 study in Science followed more than 10 million US military personnel: the risk of multiple sclerosis rose 32-fold after EBV infection, but not after other viruses. Newer work refines this. A 2026 Ontario cohort in Neurology followed 671,410 people with mono: 0.4% developed MS, after a median of 11.4 years; risk was higher in women (HR 1.9) and when mono occurred at 10 to 25 years rather than before 10 (HR 6.0). A 2026 Mayo Clinic study using lab-confirmed EBV mono found a 3-fold higher MS risk (0.17% versus 0.07%). For you: mono does not make MS likely, but new numbness, vision loss or weakness later on should be checked. Our article on EBV and MS relapses covers the latest findings.
How the immune response to EBV may drive MS
In 2026, a Science Translational Medicine study showed that people with untreated MS have twice as many CD4 T cells reacting to late "lytic" EBV proteins (the virus's capsid and envelope) as healthy controls, and that anti-CD20 therapy reduced these responses and stopped viral shedding in saliva. An antiviral trial at Massachusetts General Hospital (NCT05957913) is testing whether tenofovir/emtricitabine lowers EBV replication in MS.
EBV vaccine candidates in trials
No EBV vaccine is approved, a 2025 review in Viruses confirms, but several are in human trials. Moderna's mRNA-1189 is being tested in 867 healthy people aged 10 to 30 (NCT05164094, primary completion October 2026) and in a new intradermal study (NCT07478952). Its mRNA-1195 candidate completed a 482-participant phase 1 study (NCT05831111). The NIH tested a gp350-ferritin nanoparticle vaccine (NCT04645147, completed) and is now recruiting 750 adults for a gH/gL/gp42 nanoparticle vaccine (NCT06908096). Another mRNA candidate, VXCO-102, has a phase 1 trial in 82 healthy young adults due to start in November 2026 (NCT07557602). The hope is to prevent mono and, possibly, EBV-linked MS.
Better timing for return to sport
The 2023 splenic rupture review and the military health system data both show that some ruptures happen after the classic 3-week window. Combined with the 2024 finding that ALT and AST fall as the spleen shrinks, researchers are moving toward individualised return-to-play plans rather than a single fixed date.
Which tests can help?
Ask your doctor about:
- a complete blood count with differential and blood smear (lymphocytes, atypical lymphocytes, platelets);
- a rapid monospot test;
- EBV antibodies (VCA IgM, VCA IgG, EBNA) if the monospot is negative, the patient is a young child, or the illness is atypical;
- a rapid strep test or throat culture, since strep throat needs antibiotics;
- liver function tests (ALT, AST, bilirubin) if you have jaundice, belly pain or severe illness;
- CMV or toxoplasmosis tests if EBV tests are negative.
Glossary
- Epstein-Barr virus (EBV): a herpes virus, also called human herpesvirus 4, that causes most cases of mono and stays in the body for life.
- Heterophile antibodies: antibodies made during mono and detected by the monospot test.
- VCA: viral capsid antigen, the protein shell of EBV; IgM against it means a recent infection, IgG a current or past one.
- EBNA: EBV nuclear antigen; antibodies appear 2 to 4 months after infection and mark a past infection.
- Atypical lymphocytes: lymphocytes that look larger and different on the blood smear, typical of mono.
Frequently asked questions
Can glandular fever make you emotional?
Yes, it can. A Danish study of 1.4 million people found that mono in youth was linked to a 40% higher risk of later depression. The CDC also lists sleep disorders and, rarely, psychoses among the nervous system effects of EBV. If sadness, irritability or anxiety persist, tell your doctor.
Can I lift weights with glandular fever?
Not in the first weeks. Heavy lifting is strenuous exercise, and guidance asks you to avoid it for at least 3 weeks (AFP), with some experts advising about a month or even 8 weeks while the spleen is enlarged. One rupture in four occurs after day 21. Get your doctor's approval, then restart with light weights.
What is the virus that causes mono?
Mostly the Epstein-Barr virus, a member of the herpes virus family. Cytomegalovirus and, less often, toxoplasmosis, HIV, rubella, hepatitis viruses or adenovirus can cause a similar illness.
Is there a treatment for Epstein-Barr virus?
There is no approved antiviral or vaccine for EBV infection. Mono is treated with rest, fluids and pain relief. Cochrane reviews found that antivirals such as acyclovir and valacyclovir only suppress viral shedding during treatment, and that steroids have little proven benefit except in severe cases such as airway narrowing.
How long are you contagious with glandular fever?
While you have symptoms and possibly for a few months afterwards, according to MedlinePlus.
Can you get glandular fever twice?
Typical EBV mono happens once, because the CDC notes that VCA IgG and EBNA antibodies persist for life after infection. The virus stays in the body and can reactivate later, and a second "mono-like" illness may be caused by another germ such as CMV.
Why was my glandular fever test negative if I have symptoms?
The monospot misses many cases in the first week of illness and in children under 5. MedlinePlus explains that your doctor will then usually order EBV antibodies, and may also test for strep throat, CMV and other causes.
Sources
- Sylvester JE, Buchanan BK, Silva TW — Infectious Mononucleosis: Rapid Evidence Review — Am Fam Physician, 2023 — pubmed.ncbi.nlm.nih.gov
- Leung AKC et al. — Infectious Mononucleosis: An Updated Review — Curr Pediatr Rev, 2024 — doi.org
- Cai X, Ebell MH, Haines L — Accuracy of signs, symptoms and hematologic parameters for diagnosing infectious mononucleosis — J Am Board Fam Med, 2021 — doi.org
- Tan WJ et al. — The utility of liver function tests and abdominal ultrasound in infectious mononucleosis: a systematic review — Clin Otolaryngol, 2022 — doi.org
- Toti JMA et al. — Splenic rupture or infarction associated with Epstein-Barr virus infectious mononucleosis: a systematic literature review — Swiss Med Wkly, 2023 — doi.org
- Sylvester JE et al. — Splenic rupture and infectious mononucleosis: return-to-play recommendations — Sports Health, 2019 — doi.org
- Becker JA, Smith JA — Return to play after infectious mononucleosis — Sports Health, 2014 — doi.org
- Durtschi MS, Pham NS, Hwang CE — Liver function test results correlate with spleen size in patients with infectious mononucleosis — Cureus, 2024 — doi.org
- Torretta S et al. — Life-threatening ENT complications in pediatric EBV mononucleosis: meta-analysis — Front Pediatr, 2026 — doi.org
- Vrysis C et al. — Rash after antibiotics in infectious mononucleosis: meta-analysis — Eur J Clin Microbiol Infect Dis, 2025 — doi.org
- Rezk E et al. — Steroids for symptom control in infectious mononucleosis — Cochrane Database Syst Rev, 2015 — doi.org
- De Paor M et al. — Antiviral agents for infectious mononucleosis (glandular fever) — Cochrane Database Syst Rev, 2016 — doi.org
- Katz BZ et al. — Chronic fatigue syndrome after infectious mononucleosis in adolescents — Pediatrics, 2009 — doi.org
- Jason LA, Katz BZ — Predisposing and precipitating factors in Epstein-Barr virus-caused ME/CFS — Microorganisms, 2025 — doi.org
- Vindegaard N et al. — Infectious mononucleosis as a risk factor for depression: a nationwide cohort study — Brain Behav Immun, 2021 — doi.org
- Bjornevik K et al. — Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis — Science, 2022 — doi.org
- Rotstein DL et al. — Factors associated with rate of multiple sclerosis onset in a cohort with prior infectious mononucleosis — Neurology, 2026 — doi.org
- St Sauver JL et al. — Risk of multiple sclerosis among persons with Epstein Barr virus-positive mononucleosis: a population-based study — Neurol Open Access, 2026 — doi.org
- Bjornevik K et al. — CD4 T cells reactive to Epstein-Barr virus late lytic antigens are enriched in individuals with multiple sclerosis — Sci Transl Med, 2026 — doi.org
- Dai Y et al. — Recent progress in the vaccine development against Epstein-Barr virus — Viruses, 2025 — doi.org
- ClinicalTrials.gov — Moderna EBV vaccines mRNA-1189 (NCT05164094; also NCT07478952) and mRNA-1195 (NCT05831111) — clinicaltrials.gov
- ClinicalTrials.gov — NIAID nanoparticle EBV vaccines (NCT06908096; also NCT04645147) — clinicaltrials.gov
- ClinicalTrials.gov — VXCO-102 mRNA EBV vaccine in healthy young adults (NCT07557602) — clinicaltrials.gov
- ClinicalTrials.gov — Effects of antiviral therapies on EBV replication in MS (NCT05957913) — clinicaltrials.gov
- CDC — About Infectious Mononucleosis (Mono) — 2024 — cdc.gov
- CDC — Clinical Overview of Epstein-Barr Virus — 2024 — cdc.gov
- CDC — Laboratory Testing for Epstein-Barr Virus (EBV) — 2024 — cdc.gov
- MedlinePlus — Mononucleosis (Medical Encyclopedia) — National Library of Medicine, 2026 — medlineplus.gov
- MedlinePlus — Mononucleosis (Mono) Tests — National Library of Medicine — medlineplus.gov
- EMBL-EBI — ChEMBL: valacyclovir (CHEMBL1349), amoxicillin (CHEMBL1082) — ChEMBL — ebi.ac.uk
- NHS — Glandular fever — National Health Service — nhs.uk
Further reading
- Kissing tonsils: grades, causes and treatment
- Cobblestone throat: causes, signs and relief
- Throat herpes: symptoms, causes and treatments
- Toxoplasmosis blood tests: IgG and IgM results
- ALT to AST ratio: meaning and interpretation
- Neutrophils: what your blood test results mean
- Hepatitis blood test: what results mean
Understand your lab results with AI DiagMe
Mono shows up clearly on a few lab values: lymphocytes and atypical lymphocytes, platelets, ALT and AST, and the EBV antibody pattern. AI DiagMe reads your lab report in minutes, explains each value in plain language, shows whether your antibody results point to a recent or a past EBV infection, and suggests questions to ask your doctor. Upload your lab results to AI DiagMe for a clear, personal report.



